Apogee Therapeutics, Inc.
APGENASDAQHealthcareBiotechnology
Previous close
$134.75
$0.00 · 0.00%
APGE company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
40
Expensive
Momentum
59
Neutral
Sentiment
45
Mixed
Risk resilience
68
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteApogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Michael Thomas Henderson
- Listed since
- Jul 14, 2023
- Employees
- 261
Market position
Day range
Current $134.75
52-week range
Current $134.75
- Open
- $134.77
- Previous close
- $134.75
- Volume
- 948.28K
- 0.45× average
- Average volume
- 2.12M
- Average daily volume
- Market cap
- 8.34B USD
- Beta
- 0.34
- Market reference 1
- 50-day average
- $128.4
- +4.94% above average
- 200-day average
- $88.8973
- +51.58% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 4.46B USD
- P/E (TTM)
- -31.05×
- P/B (TTM)
- 8.51×
- P/S (TTM)
- 0×
- EV / EBITDA
- -17.54×
- Earnings yield
- -5.58%
- Free cash flow yield
- -5.08%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -28.30%
- Return on assets
- -27.30%
- Return on invested capital
- -31.29%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 26.57×
Earnings
- EPS beat rate
- 64%
- 7 beats, 4 misses, 0 met estimates
- Average EPS surprise
- +1.59%
- 11 comparable reports
- Latest EPS result
- -1.14
- Estimate -1.07 · Miss by 6.54%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
14 ratingsAPGE peers
ETFs holding APGE
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI251.67M0.01%2.3T USD0.03%$378.24+0.44%
State Street SPDR S&P Biotech ETFXBI169.94M1.49%11.39B USD0.35%$165.73+1.44%
iShares Russell 2000 ETFIWM154.91M0.19%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB90.67M0.05%183.4B USD0.03%$304.76+0.64%
Vanguard Extended Market ETFVXF86.41M0.09%93.7B USD0.05%$245.53+0.82%
Vanguard Morningstar Small-Cap Value ETFVBR57.57M0.08%68.3B USD0.05%$249.18+0.68%
iShares Biotechnology ETFIBB57.38M0.54%10.75B USD0.44%$213.56+1.29%
iShares Russell 2000 Growth ETFIWO56.47M0.38%15.16B USD0.24%$387.37+1.24%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 251.67M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
State Street SPDR S&P Biotech ETFXBI- Market value
- 169.94M
- Weight
- 1.49%
- AUM
- 11.39B USD
- Expense ratio
- 0.35%
- Price / 1D
- $165.73+1.44%
iShares Russell 2000 ETFIWM- Market value
- 154.91M
- Weight
- 0.19%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 90.67M
- Weight
- 0.05%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Extended Market ETFVXF- Market value
- 86.41M
- Weight
- 0.09%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 57.57M
- Weight
- 0.08%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
iShares Biotechnology ETFIBB- Market value
- 57.38M
- Weight
- 0.54%
- AUM
- 10.75B USD
- Expense ratio
- 0.44%
- Price / 1D
- $213.56+1.29%
iShares Russell 2000 Growth ETFIWO- Market value
- 56.47M
- Weight
- 0.38%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Continue in GoAI
Research APGEresearch.disclaimer